In 2026, screening-to-diagnostic colonoscopy conversions remain one of the most overlooked reimbursement risks for gastroenterology practices across the United States. A routine clinical decision made during a colonoscopy can trigger denials, underpayments, payment delays, and audit exposure when documentation, coding, and payer requirements are not aligned.

Sometimes in healthcare, times emerge when status quo approaches to revenue cycle strategy are no longer enough. This ti...
read more
Orthopedic billing services are the specialized revenue cycle functions that manage claim submission, coding accuracy, p...
read more
CMS finalized the 2026 Medicare Physician Fee Schedule (MPFS) in October 2025, with policies effective January 1, 2026. ...
read more
As the healthcare landscape shifts, revenue cycle leaders face increasing pressure to answer tough strategic questions. ...
read more
For clinical laboratory and pathology executives, 2026 presents a reimbursement landscape that looks fundamentally diffe...
read more
The U.S. medical billing outsourcing market – which encompasses accounts receivable management services, coding, claims ...
read more
Most healthcare organizations don't decide to outsource medical billing because of a single crisis. The decision builds ...
read more
In 2025, U.S. hospitals spent $18 billion overturning claims denials. Not losing those claims. Not writing them off. Ov...
read more
On June 1, 2026, the HHS Office of Inspector General published one of the most significant Medicare HCC risk adjustment ...
read more